No. SAMHSA's federal workplace drug testing FAQs state that an HHS change to the Authorized Drug Testing Panel, such as adding or removing a drug or changing an initial or confirmatory test analyte or cutoff, is not considered a substantive change to an agency's drug-free workplace plan. SAMHSA describes a substantive change as any alteration to a federal agency's plan that affects the substance of the plan's policy or procedures, such as adding or eliminating applicant testing. It does not refer to purely editorial changes, administrative updates or exercises of authority under the Mandatory Guidelines.
Ready to get started?